Mike Snape

3.6k total citations · 1 hit paper
25 papers, 2.7k citations indexed

About

Mike Snape is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Mike Snape has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Mike Snape's work include Neuroscience and Neuropharmacology Research (8 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mike Snape is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Genetics and Neurodevelopmental Disorders (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mike Snape collaborates with scholars based in United States, United Kingdom and Canada. Mike Snape's co-authors include Alan M. Palmer, G K Wilcock, Paul T. Francis, A.J. Cross, David Hessl, Michael R. Tranfaglia, Danh V. Nguyen, Elizabeth Berry‐Kravis, John M. Yuhas and John A. Hutchison and has published in prestigious journals such as Molecular and Cellular Biology, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Mike Snape

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1999 1.7k citations Paul T. Francis, Alan M. Palmer et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Snape United States	16	1.2k	899	746	631	535	25	2.7k
Elaine Perry United Kingdom	33	980 0.8×	1.6k 1.8×	919 1.2×	891 1.4×	813 1.5×	54	4.2k
R. G. Struble United States	13	1.2k 1.1×	1.2k 1.4×	1.1k 1.5×	1.6k 2.5×	988 1.8×	26	3.5k
Enrica Cavedo France	16	592 0.5×	622 0.7×	1.1k 1.5×	307 0.5×	447 0.8×	24	2.7k
Angelo Reggiani Italy	34	1.1k 0.9×	1.7k 1.9×	561 0.8×	2.0k 3.2×	451 0.8×	99	4.0k
Mauro Fà United States	30	944 0.8×	1.2k 1.4×	1.5k 2.0×	1.6k 2.6×	620 1.2×	46	3.6k
PJ Whitehouse United States	3	1.1k 1.0×	1.1k 1.2×	936 1.3×	1.4k 2.2×	807 1.5×	3	3.0k
Han‐Ting Zhang United States	38	1.7k 1.5×	2.7k 3.0×	841 1.1×	922 1.5×	227 0.4×	114	4.4k
Alireza Komaki‬ Iran	35	636 0.5×	1.0k 1.2×	1.0k 1.4×	1.1k 1.7×	650 1.2×	264	3.9k
Fiorella Casamenti Italy	49	1.2k 1.1×	2.3k 2.5×	2.1k 2.8×	2.1k 3.3×	968 1.8×	110	6.0k
Ewa Hellström‐Lindahl Sweden	31	978 0.8×	1.4k 1.5×	994 1.3×	601 1.0×	195 0.4×	46	2.5k

Countries citing papers authored by Mike Snape

Since Specialization

Citations

This map shows the geographic impact of Mike Snape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Snape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Snape more than expected).

Fields of papers citing papers by Mike Snape

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Snape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Snape. The network helps show where Mike Snape may publish in the future.

Co-authorship network of co-authors of Mike Snape

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Snape. A scholar is included among the top collaborators of Mike Snape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Snape. Mike Snape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horrigan, Joseph P., Mike Snape, Nikoletta Nikolenko, et al.. (2020). A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1). Pediatric Neurology. 112. 84–93. 58 indexed citations

Lochmüller, Hanns, Anna Ambrosini, Baziel G.M. van Engelen, et al.. (2019). The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, January 19-20, 2018. Journal of Neuromuscular Diseases. 6(1). 161–172. 8 indexed citations

Horrigan, Joseph P., et al.. (2018). AMO-02 (tideglusib) for the treatment of congenital and childhood onset myotonic dystrophy type 1. Neuromuscular Disorders. 28. S14–S14. 5 indexed citations

Deacon, Robert M. J., Larry Glass, Mike Snape, et al.. (2015). NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome. NeuroMolecular Medicine. 17(1). 71–82. 55 indexed citations

Neul, Jeffrey L., Daniel G. Glaze, Alan K. Percy, et al.. (2015). Improving Treatment Trial Outcomes for Rett Syndrome. Journal of Child Neurology. 30(13). 1743–1748. 54 indexed citations

Wang, Xinglong, Mike Snape, Eric Klann, et al.. (2012). Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome. Journal of Neurochemistry. 121(4). 672–679. 71 indexed citations

Bevilacqua, Francesca, et al.. (2010). Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys. American Journal of Medical Genetics Part A. 152A(6). 1420–1427. 51 indexed citations

Berry‐Kravis, Elizabeth, David Hessl, Sarah M. Coffey, et al.. (2009). A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. Journal of Medical Genetics. 46(4). 266–271. 284 indexed citations

Woods, Jack, Mike Snape, & Mark A. Smith. (2006). The cell cycle hypothesis of Alzheimer's disease: Suggestions for drug development. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(4). 503–508. 47 indexed citations

10.

Green, A R, Tracey K. Murray, Aditya Misra, et al.. (2000). The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites. British Journal of Pharmacology. 129(1). 95–100. 9 indexed citations

11.

Francis, Paul T., Alan M. Palmer, Mike Snape, & G K Wilcock. (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of Neurology Neurosurgery & Psychiatry. 66(2). 137–147. 1749 indexed citations breakdown →

12.

Snape, Mike, Aditya Misra, Tracey K. Murray, et al.. (1999). A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology. 38(1). 181–193. 76 indexed citations

13.

Misra, Anil Kumar, et al.. (1998). An Investigation of the Possible Interaction of Clomethiazole with Glutamate and Ion Channel Sites as an Explanation of its Neuroprotective Activity*. Pharmacology & Toxicology. 83(2). 90–94. 11 indexed citations

14.

Misra, Aditya, et al.. (1996). A Behavioural and Neurochemical Study in Rats of the Pharmacology of Loreclezole, a Novel Allosteric Modulator of the GABA A Receptor. Neuropharmacology. 35(9-10). 1243–1250. 23 indexed citations

15.

Cross, A.J., Tracey K. Murray, & Mike Snape. (1995). Characterisation of learning and memory deficits following NMDA receptor antagonism. Amino Acids. 8(1). 79–87. 4 indexed citations

16.

Murray, Tracey K., R.M. Ridley, Mike Snape, & A.J. Cross. (1995). The effect of dizocilpine (MK-801) on spatial and visual discrimination tasks in the rat. Behavioural Pharmacology. 6(5). 540???549–540???549. 32 indexed citations

17.

Snape, Mike, et al.. (1994). Chlormethiazole and Dizocilpine Block the Behavioural, but Not the Neurotoxic Effects of 5,7‐Dihydroxytryptamine in Mice. Pharmacology & Toxicology. 74(1). 40–42. 7 indexed citations

18.

Snape, Mike, et al.. (1993). The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 53(3). 837–844. 68 indexed citations

19.

Cross, A.J., et al.. (1993). Chlormethiazole antagonises seizures induced by N-methyl-dl-aspartate without interacting with the NMDA receptor complex. Psychopharmacology. 112(4). 403–406. 15 indexed citations

20.

Cross, A.J., et al.. (1992). The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellum. Neuroscience Letters. 138(1). 141–144. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact